Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01061294 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Outcomes Using the AMO Advanced Customvue™ iLasik Procedure
A Phase 4 study, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT01061294 is a Phase 4 study that has completed, run by Innovative Medical. The registered enrollment target is 20 participants.
The verdict
NCT01061294, a Phase 4 study, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the efficacy, predictability and safety of the Advanced CustomVue™ iLASIK procedure (WaveScan WaveFront® System, STAR S4 IR™ Excimer Laser System and IntraLase™ FS System). Patient data will be collected electronically and analyzed to determine improvements in postoperative visual acuity, visual quality and residual error.
Interventions
- PROCEDURE Advanced CustomVue™ iLASIK procedure
- DEVICE WaveScan WaveFront® System, STAR S4 IR™ Excimer Laser System and IntraLase™ FS System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-12 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01061294
The ClinicalTrials.gov registry entry for NCT01061294 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Innovative Medical, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Advanced CustomVue™ iLASIK procedure is the first listed.
NCT01061294 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01061294 about?
NCT01061294 is a clinical study titled "Evaluation of Outcomes Using the AMO Advanced Customvue™ iLasik Procedure". The purpose of this study is to assess the efficacy, predictability and safety of the Advanced CustomVue™ iLASIK procedure (WaveScan WaveFront® System, STAR S4 IR™ Excimer Laser System and IntraLase™ FS System). Patient data will be collected electronically and analyzed to determine improvements in ...
What is the current status of trial NCT01061294?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2009-12. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01061294?
The interventions under investigation include: Advanced CustomVue™ iLASIK procedure (PROCEDURE), WaveScan WaveFront® System, STAR S4 IR™ Excimer Laser System and IntraLase™ FS System (DEVICE).
Who is sponsoring clinical trial NCT01061294?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.